NCT06802406 Nutrition OUtReach In Systems of Healthcare
| NCT ID | NCT06802406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2025-05-01 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many children and adults receiving medical treatments have higher costs, which can make it harder for them to afford groceries. When someone can't afford enough food, and they do not receive proper nutrition it can make treatment more difficult. By doing this study investigators hope to learn more about whether addressing food insecurity by giving patients bags of food in clinic can help improve nutrition, reduce costs, and improve transplant and cellular therapy outcomes.
Eligibility Criteria
Inclusion Criteria: * Planning to receive transplant or cell therapy * Screen positive for food insecurity by answering "often true" or "sometimes true" to one of the following: * "Within the past 12 months, you worried that your food would run out before you got money to buy more," * "Within the past 12 months, the food you bought just didn't last and you didn't have money to get more." * Age 8 - 80 * Able to read/write English or Spanish (many patient-reported outcome measures lack validated translations in other languages) Exclusion Criteria: * Patients who do not tolerate oral nutrition at the time of study enrollment
Contact & Investigator
Anthony Sung, MD
PRINCIPAL INVESTIGATOR
The University of Kansas Cancer Center
Frequently Asked Questions
Who can join the NCT06802406 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 80 Years, studying ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06802406 currently recruiting?
Yes, NCT06802406 is actively recruiting participants. Contact the research team at asung2@kumc.edu for enrollment information.
Where is the NCT06802406 trial being conducted?
This trial is being conducted at Stanford, United States, Fairway, United States, New York, United States, Durham, United States.
Who is sponsoring the NCT06802406 clinical trial?
NCT06802406 is sponsored by University of Kansas Medical Center. The principal investigator is Anthony Sung, MD at The University of Kansas Cancer Center. The trial plans to enroll 210 participants.